Intravaginal rings for continuous low-dose administration of cervical ripening agents
Display Omitted
Autor*in: |
Wang, Yujing [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2018 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:549 ; year:2018 ; number:1 ; day:5 ; month:10 ; pages:124-132 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.ijpharm.2018.07.053 |
---|
Katalog-ID: |
ELV043944779 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV043944779 | ||
003 | DE-627 | ||
005 | 20230624105604.0 | ||
007 | cr uuu---uuuuu | ||
008 | 181113s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijpharm.2018.07.053 |2 doi | |
028 | 5 | 2 | |a GBV00000000000349.pica |
035 | |a (DE-627)ELV043944779 | ||
035 | |a (ELSEVIER)S0378-5173(18)30527-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.61 |2 bkl | ||
100 | 1 | |a Wang, Yujing |e verfasserin |4 aut | |
245 | 1 | 0 | |a Intravaginal rings for continuous low-dose administration of cervical ripening agents |
264 | 1 | |c 2018 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Display Omitted | ||
650 | 7 | |a Vaginal drug administration |2 Elsevier | |
650 | 7 | |a Out-patient |2 Elsevier | |
650 | 7 | |a Silicone elastomer drug delivery device |2 Elsevier | |
650 | 7 | |a Sustained release |2 Elsevier | |
650 | 7 | |a Controlled release |2 Elsevier | |
650 | 7 | |a Induction of labour |2 Elsevier | |
700 | 1 | |a Boyd, Peter |4 oth | |
700 | 1 | |a Hunter, Alyson |4 oth | |
700 | 1 | |a Malcolm, R. Karl |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
773 | 1 | 8 | |g volume:549 |g year:2018 |g number:1 |g day:5 |g month:10 |g pages:124-132 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2018.07.053 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
951 | |a AR | ||
952 | |d 549 |j 2018 |e 1 |b 5 |c 1005 |h 124-132 |g 9 |
author_variant |
y w yw |
---|---|
matchkey_str |
wangyujingboydpeterhunteralysonmalcolmrk:2018----:nrvgnligfrotnosodsamnsrtooc |
hierarchy_sort_str |
2018 |
bklnumber |
44.61 |
publishDate |
2018 |
allfields |
10.1016/j.ijpharm.2018.07.053 doi GBV00000000000349.pica (DE-627)ELV043944779 (ELSEVIER)S0378-5173(18)30527-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Wang, Yujing verfasserin aut Intravaginal rings for continuous low-dose administration of cervical ripening agents 2018 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour Elsevier Boyd, Peter oth Hunter, Alyson oth Malcolm, R. Karl oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:549 year:2018 number:1 day:5 month:10 pages:124-132 extent:9 https://doi.org/10.1016/j.ijpharm.2018.07.053 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 549 2018 1 5 1005 124-132 9 |
spelling |
10.1016/j.ijpharm.2018.07.053 doi GBV00000000000349.pica (DE-627)ELV043944779 (ELSEVIER)S0378-5173(18)30527-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Wang, Yujing verfasserin aut Intravaginal rings for continuous low-dose administration of cervical ripening agents 2018 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour Elsevier Boyd, Peter oth Hunter, Alyson oth Malcolm, R. Karl oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:549 year:2018 number:1 day:5 month:10 pages:124-132 extent:9 https://doi.org/10.1016/j.ijpharm.2018.07.053 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 549 2018 1 5 1005 124-132 9 |
allfields_unstemmed |
10.1016/j.ijpharm.2018.07.053 doi GBV00000000000349.pica (DE-627)ELV043944779 (ELSEVIER)S0378-5173(18)30527-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Wang, Yujing verfasserin aut Intravaginal rings for continuous low-dose administration of cervical ripening agents 2018 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour Elsevier Boyd, Peter oth Hunter, Alyson oth Malcolm, R. Karl oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:549 year:2018 number:1 day:5 month:10 pages:124-132 extent:9 https://doi.org/10.1016/j.ijpharm.2018.07.053 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 549 2018 1 5 1005 124-132 9 |
allfieldsGer |
10.1016/j.ijpharm.2018.07.053 doi GBV00000000000349.pica (DE-627)ELV043944779 (ELSEVIER)S0378-5173(18)30527-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Wang, Yujing verfasserin aut Intravaginal rings for continuous low-dose administration of cervical ripening agents 2018 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour Elsevier Boyd, Peter oth Hunter, Alyson oth Malcolm, R. Karl oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:549 year:2018 number:1 day:5 month:10 pages:124-132 extent:9 https://doi.org/10.1016/j.ijpharm.2018.07.053 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 549 2018 1 5 1005 124-132 9 |
allfieldsSound |
10.1016/j.ijpharm.2018.07.053 doi GBV00000000000349.pica (DE-627)ELV043944779 (ELSEVIER)S0378-5173(18)30527-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Wang, Yujing verfasserin aut Intravaginal rings for continuous low-dose administration of cervical ripening agents 2018 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour Elsevier Boyd, Peter oth Hunter, Alyson oth Malcolm, R. Karl oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:549 year:2018 number:1 day:5 month:10 pages:124-132 extent:9 https://doi.org/10.1016/j.ijpharm.2018.07.053 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 549 2018 1 5 1005 124-132 9 |
language |
English |
source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:549 year:2018 number:1 day:5 month:10 pages:124-132 extent:9 |
sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:549 year:2018 number:1 day:5 month:10 pages:124-132 extent:9 |
format_phy_str_mv |
Article |
bklname |
Innere Medizin |
institution |
findex.gbv.de |
topic_facet |
Vaginal drug administration Out-patient Silicone elastomer drug delivery device Sustained release Controlled release Induction of labour |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
authorswithroles_txt_mv |
Wang, Yujing @@aut@@ Boyd, Peter @@oth@@ Hunter, Alyson @@oth@@ Malcolm, R. Karl @@oth@@ |
publishDateDaySort_date |
2018-01-05T00:00:00Z |
hierarchy_top_id |
ELV008932840 |
dewey-sort |
3610 |
id |
ELV043944779 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043944779</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624105604.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2018.07.053</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000349.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043944779</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(18)30527-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wang, Yujing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intravaginal rings for continuous low-dose administration of cervical ripening agents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaginal drug administration</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Out-patient</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Silicone elastomer drug delivery device</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sustained release</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Controlled release</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Induction of labour</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boyd, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hunter, Alyson</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malcolm, R. Karl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:549</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:1</subfield><subfield code="g">day:5</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:124-132</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2018.07.053</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">549</subfield><subfield code="j">2018</subfield><subfield code="e">1</subfield><subfield code="b">5</subfield><subfield code="c">1005</subfield><subfield code="h">124-132</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
author |
Wang, Yujing |
spellingShingle |
Wang, Yujing ddc 610 bkl 44.61 Elsevier Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour Intravaginal rings for continuous low-dose administration of cervical ripening agents |
authorStr |
Wang, Yujing |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 44.61 bkl Intravaginal rings for continuous low-dose administration of cervical ripening agents Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour Elsevier |
topic |
ddc 610 bkl 44.61 Elsevier Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour |
topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour |
topic_browse |
ddc 610 bkl 44.61 Elsevier Vaginal drug administration Elsevier Out-patient Elsevier Silicone elastomer drug delivery device Elsevier Sustained release Elsevier Controlled release Elsevier Induction of labour |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
p b pb a h ah r k m rk rkm |
hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
hierarchy_parent_id |
ELV008932840 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV008932840 |
title |
Intravaginal rings for continuous low-dose administration of cervical ripening agents |
ctrlnum |
(DE-627)ELV043944779 (ELSEVIER)S0378-5173(18)30527-1 |
title_full |
Intravaginal rings for continuous low-dose administration of cervical ripening agents |
author_sort |
Wang, Yujing |
journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2018 |
contenttype_str_mv |
zzz |
container_start_page |
124 |
author_browse |
Wang, Yujing |
container_volume |
549 |
physical |
9 |
class |
610 VZ 44.61 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Wang, Yujing |
doi_str_mv |
10.1016/j.ijpharm.2018.07.053 |
dewey-full |
610 |
title_sort |
intravaginal rings for continuous low-dose administration of cervical ripening agents |
title_auth |
Intravaginal rings for continuous low-dose administration of cervical ripening agents |
abstract |
Display Omitted |
abstractGer |
Display Omitted |
abstract_unstemmed |
Display Omitted |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
container_issue |
1 |
title_short |
Intravaginal rings for continuous low-dose administration of cervical ripening agents |
url |
https://doi.org/10.1016/j.ijpharm.2018.07.053 |
remote_bool |
true |
author2 |
Boyd, Peter Hunter, Alyson Malcolm, R. Karl |
author2Str |
Boyd, Peter Hunter, Alyson Malcolm, R. Karl |
ppnlink |
ELV008932840 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.ijpharm.2018.07.053 |
up_date |
2024-07-06T20:10:28.200Z |
_version_ |
1803861757211443200 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043944779</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624105604.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2018.07.053</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000349.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043944779</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(18)30527-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wang, Yujing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intravaginal rings for continuous low-dose administration of cervical ripening agents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaginal drug administration</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Out-patient</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Silicone elastomer drug delivery device</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sustained release</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Controlled release</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Induction of labour</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boyd, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hunter, Alyson</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Malcolm, R. Karl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:549</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:1</subfield><subfield code="g">day:5</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:124-132</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2018.07.053</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">549</subfield><subfield code="j">2018</subfield><subfield code="e">1</subfield><subfield code="b">5</subfield><subfield code="c">1005</subfield><subfield code="h">124-132</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
score |
7.4010878 |